Polyrizon Ltd.
corporate_fare Company Profile
Polyrizon Ltd. (NASDAQ:PLRZ) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors PLRZ SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Polyrizon's Nasal Drug Delivery Patent Application Published in Europe
- Polyrizon Proposes Substantial Executive & Director Equity Awards, Amends Compensation Policy
- Polyrizon Secures Three Key U.S. Clinical Sites for NASARIX™ Allergy Blocker Trial
- Three Major U.S. Sites Secured for Polyrizon's NASARIX™ Allergy Blocker Trial
- Polyrizon Extends Exclusivity for Proposed 51% Stake Acquisition in Arrow Aviation
Financial Snapshot
Insider Transactions
PLRZ files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.